What are the opening hours?

Monday 10:00 - 18:00 Tuesday 10:00 - 18:00 Wednesday 10:00 - 18:00 Thursday 10:00 - 18:00 Friday 10:00 - 18:00

Gorgio International Holding

Home
Georgia
Tbilisi
Gorgio International Holding

A Novel Path Toward the Worldwide Trade

Gorgio International Holding (გორგიო ინთერნშნალ ჰოლდინგი) is a British-Georgian commercial holding company established in 2021. Our holding brings together leading international scientists, business professionals, economists, and inventors, all united in our mission to drive innovation and investment in novel business ventures. Each of Gorgio's diverse activities is independently managed by one of our subsidiary brands, with Gorgio providing strategic oversight and coordination. Our Activities
Gorgio International Holding engages in a broad spectrum of economic and commercial activities, encompassing production, trade, and high-tech industries. Our operations include the establishment of new companies and active investment in various ventures, with key objectives as follows:
- Leading production, trade, and high-tech initiatives
- Investing in both national and international projects, and collaborating with other venture capital and investment firms within specialized sectors
- Managing comprehensive import and export activities

Our Subsidiaries & Brands
- Quatech (www.quatech.co)
- Aglitter (www.aglitter.co)
- Chainsus (www.chainsus.io)
- NH (www.nh.ge)

10/02/2026

We are honored to collaborate with Edinburgh’s pioneering cancer research community. From precision medicine to immunotherapy and patient support services, Edinburgh’s commitment to innovation is helping change the course of cancer care.

Together, we can accelerate breakthroughs and improve lives.

Read more: https://www.edinburghnews.scotsman.com/community/edinburghs-pioneering-efforts-in-cancer-research-a-city-at-the-forefront-of-medical-innovation-5512218

24/12/2025

Merry Christmas!
From all of us at Gorgio International Holding, wishing you a joyful holiday season and a prosperous New Year.

21/11/2025

Blockchain in 2025 is entering a pivotal phase with clearer regulation, rapid growth in tokenization, and rising security challenges in DeFi. As a subsidiary of Gorgio International Holding, Chainsus is helping enterprises navigate this evolving landscape with secure and scalable Web3 solutions. The future of blockchain is taking shape and we are building toward it.

Read the full article here: https://newsbywire.com/blockchain-in-2025-key-trends-risks-and-the-future-of-web3/

17/10/2025

Improving Healthcare Access in Newry: A Step Toward Integrated Care!

At Gorgio International Holding, we recognize the importance of improving healthcare access and integration in communities like Newry. As local healthcare services evolve, our collective focus must be on reducing wait times, enhancing care continuity, and supporting patients with complex needs.

🔗 https://www.newryreporter.com/health/opinion-bridging-the-health-gap-what-the-newry-health-hub-will-mean-for-local-patients-5363608

08/10/2025

A New Era in Cancer Care Has Arrived!
In 2025, cancer treatment is being transformed by two revolutionary forces: Artificial Intelligence and Immunotherapy.

From AI-driven diagnostics like DeepHRD to personalised immunotherapies and AI-designed cancer vaccines, the convergence of tech and biology is reshaping outcomes — and lives.

This is more than innovation. It’s precision oncology in action, offering patients earlier diagnoses, smarter therapies, and real hope.

Explore how science, technology, and human stories are rewriting the future of cancer care:
🔗 https://www.londondaily.news/the-dawn-of-a-new-era-in-cancer-care-how-ai-and-immunotherapy-are-changing-lives/

19/09/2025

🚨 Global Recognition for Gorgio International Holding's Pioneering Cancer Therapies

We are proud to announce that Gorgio International Holding (GIH) has been featured in NationalWorld for our innovative approach to treating epithelial cancers. Our Quatech Research Division has developed next-generation therapies and nutritional supplements in collaboration with leading oncologists worldwide. These advancements aim to transform the management of cancers such as lung, breast, colorectal, and prostate by targeting key molecular drivers and enhancing immune response.

This recognition underscores our commitment to scientific excellence and global collaboration in oncology. As we prepare for the upcoming launch, we remain dedicated to improving patient outcomes through precision medicine and integrative care.

Read the full article:
🔗https://www.nationalworld.com/health/next-generation-cancer-therapies-target-epithelial-tumors-with-breakthrough-scientific-advances-5326154

18/09/2025

🚨 Breaking News from Gorgio International Holding

We are honored to be featured in The Scotsman, spotlighting a major milestone in our mission to transform cancer care.

Backed by Gorgio Holding, our Quatech Research Center is on the verge of launching innovative anti-cancer drugs and nutritional supplements that carry global implications for oncology and beyond.

Our latest breakthroughs are designed to:
✔️ Target epithelial cancers more effectively
✔️ Support global treatment protocols
✔️ Reduce side effects
✔️ Elevate patient quality of life

This initiative represents a fusion of scientific excellence and international collaboration — with a focus on making life-saving innovations accessible to patients worldwide.

Read the full coverage here:
🔗 https://www.scotsman.com/health/gorgio-international-holding-to-unveil-groundbreaking-cancer-therapies-and-supplements-developed-with-leading-oncologists-5318619

15/09/2025

🚨 Major Announcement from Gorgio International Holding

We are proud to share a feature in the Derry Journal announcing GIH’s upcoming launch of groundbreaking cancer therapies and nutritional supplements, developed in close collaboration with leading global oncologists.

Through our research arm, Quatech Research Center, our team of top-tier scientists and clinicians has been working tirelessly to develop advanced formulations targeting epithelial cancers — one of the most prevalent forms worldwide.

These innovations aim to:
✔️ Complement existing cancer treatments
✔️ Improve patient outcomes
✔️ Minimize side effects
✔️ Enhance quality of life

This is more than science — it’s a global collaboration powered by visionary leadership and unwavering commitment to better outcomes for cancer patients everywhere.

Read the full article here:
🔗 https://www.derryjournal.com/health/gorgio-international-holding-to-unveil-groundbreaking-cancer-therapies-and-supplements-developed-with-leading-oncologists-5318619

Address

Space N7, N2a Leonidze Str. , Freedom Square
Tbilisi
0105

Opening Hours

Monday	10:00 - 18:00
Tuesday	10:00 - 18:00
Wednesday	10:00 - 18:00
Thursday	10:00 - 18:00
Friday	10:00 - 18:00

Website

https://gorgio.ge/

Alerts

Be the first to know and let us send you an email when Gorgio International Holding posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Finance Company in Tbilisi?